Neogenomics Inc (NEO)

Feb 25, 2025

NeoGenomics stock hits 52-week low at $10.68 amid challenges By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

NeoGenomics stock hits 52-week low at $10.68 amid challenges - Investing.com India

Feb 25, 2025

Feb 24, 2025

NeoGenomics to Participate in Upcoming Investor Conferences - The Bakersfield Californian

Feb 24, 2025

Feb 24, 2025

Healthcare Diagnostics Leader NeoGenomics Lines Up Triple Conference ShowcaseKey Dates Inside - StockTitan

Feb 24, 2025

Feb 24, 2025

Tumor Tracking Systems Market Generated Opportunities, Future - openPR

Feb 24, 2025

Feb 22, 2025

NeoGenomics price target lowered to $17 from $18 at BTIG - MSN

Feb 22, 2025

Feb 21, 2025

NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance - MSN

Feb 21, 2025

Feb 20, 2025

Bank of America Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price - MarketBeat

Feb 20, 2025

Feb 20, 2025

NeoGenomics (NASDAQ:NEO) Price Target Cut to $18.00 by Analysts at Needham & Company LLC - MarketBeat

Feb 20, 2025

Feb 19, 2025

NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 - ACCESS Newswire

Feb 19, 2025

Feb 19, 2025

BTIG cuts Neogenomics price target to $17, maintains Buy rating - Investing.com India

Feb 19, 2025

Feb 19, 2025

BTIG cuts Neogenomics price target to $17, maintains Buy rating By Investing.com - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2024 Earnings Call Transcript - MSN

Feb 19, 2025

Feb 19, 2025

NeoGenomics (NASDAQ:NEO) Sets New 52-Week Low After Earnings Miss - MarketBeat

Feb 19, 2025

Feb 19, 2025

Morgan Stanley cuts Neogenomics stock target to $17 from $18 By Investing.com - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

NeoGenomics (NASDAQ:NEO) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat

Feb 19, 2025

Feb 19, 2025

NeoGenomics price target lowered to $19 from $20 at TD Cowen - TipRanks

Feb 19, 2025

Feb 19, 2025

NeoGenomics (NASDAQ:NEO) Issues Earnings Results - MarketBeat

Feb 19, 2025

Feb 19, 2025

NeoGenomics targets 1M patients annually by 2028 with 11%-13% revenue growth in 2025 - MSN

Feb 19, 2025

Feb 19, 2025

Demystifying NeoGenomics: Insights From 6 Analyst Reviews - Benzinga

Feb 19, 2025

Feb 19, 2025

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 19, 2025

Feb 19, 2025

NeoGenomics: Q4 Earnings Snapshot - CT Insider

Feb 19, 2025

Feb 19, 2025

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

Parp Inhibitor Biomarkers Market Future Business - openPR

Feb 19, 2025

Feb 18, 2025

NeoGenomics Achieves Double-Digit Revenue Growth in 2024 - TipRanks

Feb 18, 2025

Feb 18, 2025

Raymond James holds Neogenomics at Market Perform By Investing.com - Investing.com Nigeria

Feb 18, 2025

Feb 18, 2025

NeoGenomics Q4 Earnings Call Highlights Growth Amid Challenges - TipRanks

Feb 18, 2025

Feb 18, 2025

NeoGenomics Quarterly Results: Shares Plummet Amidst Financial ConcernsNews and Statistics - IndexBox, Inc.

Feb 18, 2025

Feb 18, 2025

Why NeoGenomics (NEO) Shares Are Trading Lower Today - The Globe and Mail

Feb 18, 2025

Feb 18, 2025

Why NeoGenomics (NEO) Shares Are Trading Lower Today By Stock Story - Investing.com Canada

Feb 18, 2025

Feb 18, 2025

NeoGenomics stock tumbles on weak EPS guidance By Investing.com - Investing.com Nigeria

Feb 18, 2025

Feb 18, 2025

Trend Tracker for (NEO) - Stock Traders Daily

Feb 18, 2025

Feb 18, 2025

NeoGenomics (NEO) Tops Q4 Earnings Estimates - MSN

Feb 18, 2025

Feb 18, 2025

Earnings call transcript: NeoGenomics Q4 2024 earnings beat expectations, stock drops - Investing.com

Feb 18, 2025

Feb 18, 2025

NeoGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Raymond James holds Neogenomics at Market Perform - Investing.com India

Feb 18, 2025

Feb 18, 2025

Neogenomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 18, 2025

Feb 18, 2025

Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt - Simply Wall St

Feb 18, 2025

Feb 18, 2025

NeoGenomics reports Q4 adjusted EPS 4c, consensus 3c - TipRanks

Feb 18, 2025

Feb 18, 2025

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results - BioSpace

Feb 18, 2025

Feb 18, 2025

NEOGENOMICS Earnings Results: $NEO Reports Quarterly Earnings - Nasdaq

Feb 18, 2025

Feb 18, 2025

(NEO) NeoGenomics Expects Full Year 2025 Consolidated Revenue Range $735M$745M, vs. FactSet Est of $733.1M - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Earnings Flash (NEO) NeoGenomics Posts Q4 Revenue $172M, vs. FactSet Est of $173.2M - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Neogenomics Inc Reaffirms Full-Year 2025 Guidance -February 18, 2025 at 07:19 am EST - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets - Yahoo Finance

Feb 18, 2025

Feb 17, 2025

Not Just a DEX: How Pineapple’s Mystery Marketing is Changing the Game - GlobeNewswire Inc.

Feb 17, 2025

Feb 17, 2025

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect - MSN

Feb 17, 2025

Feb 17, 2025

NeoGenomics Set to Surpass Revenue Growth ProjectionsNews and Statistics - IndexBox, Inc.

Feb 17, 2025

Feb 16, 2025

Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) Target Price at $20.20 - MarketBeat

Feb 16, 2025

Feb 14, 2025

NeoGenomics (NEO) Projected to Post Earnings on Tuesday - MarketBeat

Feb 14, 2025

Feb 14, 2025

NeoGenomics Q4 2024 Earnings Preview - MSN

Feb 14, 2025